Alterity Therapeutics (ATHE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alterity Therapeutics Limited has reported a change in the interest of directors Mr. Brian Meltzer and Mr. Peter Marks as per the ASX listing rules. The change, dated 31st August 2024, involves the expiry of unlisted options without exercise or conversion. No new securities were acquired, but both directors saw a decrease in the number of options held.
For further insights into ATHE stock, check out TipRanks’ Stock Analysis page.